868 F.3d 231 (3rd Cir. 2017), 14-4202, In re Lipitor Antitrust Litigation

Docket Nº14-4202, 14-4203, 14-4204, 14-4205, 14-4206, 14-4602, 15-1184, 15-1185, 15-1186, 15-1187, 15-1274, 15-1323, 15-1342
Citation868 F.3d 231
Opinion JudgeSMITH, Chief Judge.
Party NameIn re: LIPITOR ANTITRUST LITIGATION, RITE AID CORPORATION; RITE AID HDQTRS CORPORATION; JCG (PJC) USA, LLC; MAXI DRUG, INC. d/b/a Brooks Pharmacy; ECKERD CORPORATION, Appellants in No. 14-4202, WALGREEN COMPANY; THE KROGER COMPANY; SAFEWAY, INC.; SUPERVALU, INC.; HEB GROCERY COMPANY L.P., Appellants in No. 14-4203, GIANT EAGLE, INC., Appellant in N
AttorneyFor Rite Aid Corp., Rite Aid Hdqtrs. Corp., Maxi Drug Inc., Eckerd Corp. and JCG (PJC) USA LLC, Appellants: Monica L. Kiley, Hangley Aronchick Segal Pudlin & Schiller, Harrisburg, PA; Maureen S. Lawrence, Barry L. Refsin [ARGUED], Philadelphia, PA. For Walgreen Co., Kroger Co., Safeway Inc., Supe...
Judge PanelBefore: SMITH, Chief Judge, AMBRO, and FISHER, Circuit Judges.
Case DateAugust 21, 2017
CourtUnited States Courts of Appeals, Court of Appeals for the Third Circuit

Page 231

868 F.3d 231 (3rd Cir. 2017)

In re: LIPITOR ANTITRUST LITIGATION, RITE AID CORPORATION; RITE AID HDQTRS CORPORATION; JCG (PJC) USA, LLC; MAXI DRUG, INC. d/b/a Brooks Pharmacy; ECKERD CORPORATION, Appellants in No. 14-4202, WALGREEN COMPANY; THE KROGER COMPANY; SAFEWAY, INC.; SUPERVALU, INC.; HEB GROCERY COMPANY L.P., Appellants in No. 14-4203, GIANT EAGLE, INC., Appellant in No. 14-4204, MEIJER INC.; MEIJER DISTRIBUTION, INC., Appellants in No. 14-4205, ROCHESTER DRUG CO-OPERATIVE, INC.; STEPHEN L. LAFRANCE PHARMACY, INC. d/b/a SAJ DISTRIBUTORS; BURLINGTON DRUG COMPANY, INC.; VALUE DRUG COMPANY; PROFESSIONAL DRUG COMPANY, INC.; AMERICAN SALES COMPANY LLC, Appellants in No. 14-4206, A.F.L.-A.G.C. BUILDING TRADES WELFARE PLAN; MAYOR AND CITY COUNCIL OF BALTIMORE, MARYLAND; NEW MEXICO UNITED FOOD AND COMMERCIAL WORKERS UNION'S AND EMPLOYERS' HEALTH AND WELFARE TRUST FUND; LOUISIANA HEALTH SERVICE INDEMNITY COMPANY, d/b/a BLUE CROSS/BLUE SHIELD OF LOUISIANA; BAKERS LOCAL 433 HEALTH FUND; TWIN CITIES BAKERY WORKERS HEALTH AND WELFARE FUND; FRATERNAL ORDER OF POLICE, FORT LAUDERDALE LODGE 31, INSURANCE TRUST FUND; INTERNATIONAL BROTHERHOOD OF ELECTRICAL WORKERS LOCAL 98; NEW YORK HOTEL TRADES COUNSEL & HOTEL ASSOCIATION OF NEW YORK CITY, INC., HEALTH BENEFITS FUND; EDWARD CZARNECKI; EMILIE HEINLE; FRANK PALTER; ANDREW LIVEZEY; EDWARD ELLENSON; JEAN ELLYNE DOUGAN; NANCY BILLINGTON, ON BEHALF OF THEMSELVES AND ALL OTHERS SIMILARLY SITUATED, Appellants in No. 14-4602; IN RE: EFFEXOR XR ANTITRUST LITIGATION, WALGREEN, CO.; THE KROGER, CO.; SAFEWAY, INC.; SUPERVALU, INC.; HEB GROCERY COMPANY LP; AMERICAN SALES COMPANY, INC., Appellants in No. 15-1184, RITE AID CORPORATION; RITE AID HDQTRS., CORPORATION; JCG (PJC) USA, LLC; MAXI DRUG, INC. d/b/a BROOKS PHARMACY; ECKERD CORPORATION; CVS CAREMARK CORPORATION, Appellants in No. 15-1185, GIANT EAGLE, INC., Appellant in No. 15-1186, MEIJER, INC.; MEIJER DISTRIBUTION, INC., Appellants in No. 15-1187, PROFESSIONAL DRUG COMPANY, INC.; ROCHESTER DRUG CO-OPERATIVE, INC.; STEPHEN L. LAFRANCE HOLDINGS, INC.; STEPHEN L. LAFRANCE PHARMACY, INC. d/b/a SAJ DISTRIBUTORS; UNIONDALE CHEMIST, INC., Appellants in No. 15-1274, PAINTERS DISTRICT COUNCIL NO. 30 HEALTH & WELFARE FUND; MEDICAL MUTUAL OF OHIO, Appellants in No. 15-1323, A.F. of L.-A.G.C. BUILDING TRADES WELFARE PLAN; DARYL DEINO; IBEW-NECA LOCAL 505 HEALTH & WELFARE PLAN; LOUISIANA HEALTH SERVICE INDEMNITY COMPANY d/b/a BLUE CROSS/BLUE SHIELD OF LOUISIANA; MAN-U SERVICE CONTRACT TRUST FUND; MC-UA LOCAL 119 HEALTH & WELFARE PLAN; NEW MEXICO UNITED FOOD AND COMMERCIAL WORKERS UNION'S AND EMPLOYERS' HEALTH AND WELFARE TRUST FUND; PLUMBERS AND PIPEFITTERS LOCAL 572 HEALTH AND WELFARE FUND; SERGEANTS BENEVOLENT ASSOCIATION HEALTH AND WELFARE FUND; PATRICIA SUTTER (TOGETHER " END-PAYOR CLASS PLAINTIFFS" ) ON BEHALF OF THEMSELVES AND ALL OTHERS SIMILARLY SITUATED, Appellants in No. 15-1342

Nos. 14-4202, 14-4203, 14-4204, 14-4205, 14-4206, 14-4602, 15-1184, 15-1185, 15-1186, 15-1187, 15-1274, 15-1323, 15-1342

United States Court of Appeals, Third Circuit

August 21, 2017

Argued May 19, 2017

Page 232

[Copyrighted Material Omitted]

Page 233

[Copyrighted Material Omitted]

Page 234

[Copyrighted Material Omitted]

Page 235

[Copyrighted Material Omitted]

Page 236

[Copyrighted Material Omitted]

Page 237

[Copyrighted Material Omitted]

Page 238

On Appeal from the United States District Court for the District of New Jersey. (MDL 2332) / (D.N.J. No. 3-12-cv-02389) / (D.N.J. No. 3-12-cv-02478) / (D.N.J. No. 3-12-cv-04115) / (D.N.J. No. 3-12-cv-04537) / (D.N.J. No. 3-12-cv-05129) / (D.N.J. No. 3-12-cv-06774) / (D.N.J. No. 3-12-cv-07561) / (D.N.J. No. 3-11-cv-05479) / (D.N.J. No. 3-11-cv-05590) / (D.N.J. No. 3-11-cv-05661) / (D.N.J. No. 3-11-cv-06985) / (D.N.J. No. 3-11-cv-07504) / (D.N.J. No. 3-12-cv-03116) / (D.N.J. No. 3-12-cv-03523). District Judge: The Honorable Peter G. Sheridan.

In re Lipitor Antitrust Litig., 46 F.Supp.3d 523, (D.N.J., Sept. 12, 2014)

In re Lipitor Antitrust Litig., (D.N.J., Oct. 30, 2014)

In re Effexor XR Antitrust Litig., (D.N.J., Oct. 6, 2014)

For Rite Aid Corp., Rite Aid Hdqtrs. Corp., Maxi Drug Inc., Eckerd Corp. and JCG (PJC) USA LLC, Appellants: Monica L. Kiley, Hangley Aronchick Segal Pudlin & Schiller, Harrisburg, PA; Maureen S. Lawrence, Barry L. Refsin [ARGUED], Hangley Aronchick Segal Pudlin & Schiller, Philadelphia, PA.

For Walgreen Co., Kroger Co., Safeway Inc., Supervalu, Inc., HEB Grocery Co. LP and American Sales Co. LLC, Appellants: Anna T. Neill, Scott E. Perwin [ARGUED], Lauren C. Ravkind, Kenny Nachwalter, P.A., Miami, FL.

For Giant Eagle, Inc., Appellant: David P. Germaine, Joseph M. Vanek, Vanek, Vickers & Masini, P.C., Chicago, IL; Moira Cain-Mannix, Bernard D. Marcus, Erin G. Allen, Marcus & Shapira LLP, Pittsburgh, PA.

For Meijer, Inc. and Meijer Distribution, Appellants: Bradley J. Demuth, Linda P. Nussbaum, Nussbaum Law Group P.C., New York, NY; David P. Germaine, Joseph M. Vanek, Vanek Vickers & Masini, Chicago, IL.

For Direct-Purchaser Class Plaintiffs Rochester Drug Co-Operative, Inc., et al., Appellants: Gregory T. Arnold, Kristen A. Johnson, Kristie A. LaSalle, Thomas M. Sobol [ARGUED], Hagens Berman Sobol & Shapiro LLP, Cambridge, MA; Caitlin Coslett, Eric L. Cramer, Jennifer MacNaughton, Daniel Simons, David F. Sorensen [ARGUED], Richard D. Schwartz, Berger & Montague, P.C., Philadelphia, PA; Elena K. Chan, Bruce E. Gerstein [ARGUED], Kimberly Hennings, Garwin Gerstein & Fisher LLP, New York, NY; Peter Kohn, Richard D. Schwartz, Faruqi & Faruqi LLP, Jenkintown, PA; Miles Greaves, Barry S. Taus, Taus Cebulash & Landau, LLP, New York, NY; Erin C. Burns, Dianne M. Nast, NastLaw LLC, Philadelphia, PA; Don Barrett, Barrett Law Group, Lexington, MS.

For Direct-Purchaser Class Plaintiffs Rochester Drug Co-Operative, Inc., et al., Appellants: James E. Cecchi [ARGUED], Lindsey H. Taylor, Carella, Byrne, Cecchi, Olstein, Brody, & Agnello, P.C., Roseland, NJ; Peter S. Pearlman, Cohn Lifland Pearlman Herrmann & Knopf LLP, Saddle Brook, NJ.

For End-Payor Class Plaintiffs AFL-AGC Building Trades Welfare Plan, et al., Appellants: Justin N. Boley, Bethany R. Turke, Kenneth A. Wexler, Wexler Wallace LLP, Chicago, IL; James W. Anderson, Vincent J. Esades, Renae Steiner, David R. Woodward [ARGUED], Heins Mills & Olson, P.L.C., Minneapolis, MN; J. Douglas Richards, Sharon K. Robertson, Cohen Milstein Sellers & Toll, PLLC, New York, NY; Michael M. Buchman, Alex Straus, Esq., Motley Rice LLC, New York, NY; Jeffrey L. Kodroff, John A. Macoretta, Spector Roseman Kodroff & Willis, Philadelphia, PA.

For End-Payor Class Plaintiffs AFL-AGC Building Trades Welfare Plan, et al., Appellants: Lisa J. Rodriguez, Schnader Harrison Segal & Lewis LLP, Woodland Falls Corporate Park, Cherry Hill, NJ.

For Painters District Council No. 30 Health & Welfare Fund and Medical Mutual of Ohio, Appellants: Joseph M. Alioto, Jamie L. Miller, Theresa Driscoll Moore, Alioto Law Firm, San Francisco, CA; Timothy A.C. May, Gil D. Messina, Messina Law Firm, P.C., Holmdel, NJ; Lori A. Fanning, Marvin A. Miller, Matthew E. Van Tine, Miller Law LLC, Chicago, IL; Kevin P. Roddy, Wilentz, Goldman & Spitzer, P.A., Woodbridge, NJ; Mark S. Sandmann, Hill Carter Franco Cole & Black, P.C., Louisville, KY.

For 48 Law, Economics, and Business Professors and the American Antitrust Institute as Amici Curiae in support of Appellants: Steve D. Shadowen, Hilliard & Shadowen LLP, Austin, TX; Michael A. Carrier, Rutgers Law School, Camden, NJ.

For Federal Trade Commission as Amicus Curiae in support of Appellants: Jonathan E. Nuechterlein, Former General Counsel David C. Shonka, Acting General Counsel, Joel Marcus, Director of Litigation, Michele Arington, Assistant General Counsel, Deborah L. Feinstein, Director, Markus H. Meier, Acting Deputy Director, Bradley S. Albert, Deputy Assistant Director, Elizabeth R. Hilder, Heather Johnson, Jamie R. Towey, Federal Trade Commission, Washington, DC.

For Pfizer, Inc., Pfizer Ireland Pharmaceuticals, Warner-Lambert Company, Warner-Lambert Company LLC, Wyeth, Inc., Wyeth Pharmaceuticals, Inc., Wyeth-Whitehall Pharmaceuticals LLC and Wyeth Pharmaceuticals Company, Appellees: Dimitrios T. Drivas, Raj S. Gandesha, Bryan D. Gant, Sheryn E. George, Robert A. Milne [ARGUED], Brendan G. Woodard, Amy E. Boddorff, White & Case LLP, New York, NY; Liza M. Walsh, Eleonore Ofosu-Antwi, Walsh Pizzi O'Reilly & Falanga, Newark, NJ.

For Ranbaxy, Inc., Ranbaxy Pharmaceuticals, Inc., Ranbaxy Laboratories Ltd., Teva Pharmaceutical Industries Ltd. and Teva Pharmaceuticals USA, Inc., Appellees: Jonathan D. Janow, John C. O'Quinn, Gregory L. Skidmore, Edwin J. U, Karen N. Walker, Kirkland & Ellis LLP, Washington, DC; Jay P. Lefkowitz [ARGUED], Joseph Serino, Jr., Steven J. Menashi, Kirkland & Ellis LLP, New York, NY.

For American Tort Reform Association and Pharmaceutical Research and Manufacturers of America as Amici Curiae in support of Appellees: Katherine A. Helm, Noah M. Leibowitz, Simpson Thacher & Bartlett LLP, New York, NY; Victor E. Schwartz, Philip S. Goldberg, Cary Silverman, Shook, Hardy & Bacon L.L.P., Washington, DC.

For Antitrust Economists as Amici Curiae in support of Appellees: Jonathan D. Hacker, Edward Hassi, O'Melveny & Myers LLP, Washington, DC.

For Pharmaceutical Research and Manufacturers of America as Amicus Curiae in support of Appellees: Ashley Bass, Stephen Bartenstein, Andrew D. Lazerow, Covington & Burling LLP, Washington, D.C.

For Generic Pharmaceutical Association as Amicus Curiae in support of Appellees: Roy Chamcharas, Peter J. Curtin, William A. Rakoczy, Molino Mazzochi & Siwik LLP, Chicago, IL; Brian T. Burgess, Goodwin Procter LLP, Washington, DC; Christopher T. Holding, Goodwin Procter LLP, Boston, MA.

Before:...

To continue reading

Request your trial
59 practice notes
  • Federal Trade Commission v. AbbVie Inc., 093020 FED3, 18-2621
    • United States
    • Federal Cases United States Courts of Appeals Court of Appeals for the Third Circuit
    • 30 September 2020
    ...settlement at issue involves a large and unjustified reverse payment under Actavis." In re Lipitor Antitrust Litig., 868 F.3d 231, 252 (3d Cir. 2017) (citation 1. Actavis A reverse payment occurs when a patentee pays an alleged infringer to end a lawsuit. ......
  • Matrix Distributors, Inc. v. National Association of Boards of Pharmacy, 120420 NJDC, Civ. 18-17462 (KM) (MAH)
    • United States
    • Federal Cases United States District Courts 3th Circuit District of New Jersey
    • 4 December 2020
    ...Matrix and PriMed's motion for relief from judgment; I can only notice their existence. See In re Lipitor Antitrust Litig., 868 F.3d 231, 269 (3d Cir. 2017) (improper to “[t]ak[e] judicial notice of the truth of the contents of a filing from a related action” (citat......
  • Somaxon Pharmaceuticals Inc. v. Actavis Elizabeth LLC, 040920 DEDC, C. A. 10-1100-RGA-MPT
    • United States
    • Federal Cases United States District Courts 3th Circuit District of Delaware
    • 9 April 2020
    ...the Supreme Court's ruling in FTC v. Actavis to non-monetary reverse payments. See, e.g., In re Lipitor Antitrust Litig., 868 F.3d 231, 252 (3d Cir. 2017); King Drug Co. of Florence, Inc. v. Smithkline Beecham Corp., 791 F.3d 388, 403 (3d Cir. 2015), cert. denied, 1......
  • Gurvey v. M&T Bank, Inc., 121720 NJDC, C. A. 20-7831 (SDW) (LDW)
    • United States
    • Federal Cases United States District Courts 3th Circuit District of New Jersey
    • 17 December 2020
    ...F.3d 1410, 1426 (3d Cir. 1997) (internal citations omitted, emphasis in original); see also In re Lipitor Antitrust Litig., 868 F.3d 231, 249 (3d Cir. 2017), or matters of public record, Chugh v. W. Inventory Servs., Inc., 333 F.Supp. 285, 289 (D.N.J. 2004). Because......
  • Request a trial to view additional results
57 cases
  • Federal Trade Commission v. AbbVie Inc., 093020 FED3, 18-2621
    • United States
    • Federal Cases United States Courts of Appeals Court of Appeals for the Third Circuit
    • 30 September 2020
    ...settlement at issue involves a large and unjustified reverse payment under Actavis." In re Lipitor Antitrust Litig., 868 F.3d 231, 252 (3d Cir. 2017) (citation 1. Actavis A reverse payment occurs when a patentee pays an alleged infringer to end a lawsuit. ......
  • Matrix Distributors, Inc. v. National Association of Boards of Pharmacy, 120420 NJDC, Civ. 18-17462 (KM) (MAH)
    • United States
    • Federal Cases United States District Courts 3th Circuit District of New Jersey
    • 4 December 2020
    ...Matrix and PriMed's motion for relief from judgment; I can only notice their existence. See In re Lipitor Antitrust Litig., 868 F.3d 231, 269 (3d Cir. 2017) (improper to “[t]ak[e] judicial notice of the truth of the contents of a filing from a related action” (citat......
  • Somaxon Pharmaceuticals Inc. v. Actavis Elizabeth LLC, 040920 DEDC, C. A. 10-1100-RGA-MPT
    • United States
    • Federal Cases United States District Courts 3th Circuit District of Delaware
    • 9 April 2020
    ...the Supreme Court's ruling in FTC v. Actavis to non-monetary reverse payments. See, e.g., In re Lipitor Antitrust Litig., 868 F.3d 231, 252 (3d Cir. 2017); King Drug Co. of Florence, Inc. v. Smithkline Beecham Corp., 791 F.3d 388, 403 (3d Cir. 2015), cert. denied, 1......
  • In re Donaghy, 040419 PAEBC, 18-15459 ELF
    • United States
    • Federal Cases United States Bankruptcy Courts Third Circuit
    • 4 April 2019
    ...contract principles are applied to determine the meaning of an ambiguous consent order. See In re Lipitor Antitrust Litig., 868 F.3d 231, 265 (3rd Cir. 2017); John Deere Co. v. Haverlak, 2009 WL 3806709, at *2 (M.D. Pa. Nov. 12, 2009). But, whatever the order is determin......
  • Request a trial to view additional results
2 firm's commentaries
  • The Federal Trade Commission Slams Impax/Endo Reverse Payment Settlement
    • United States
    • Mondaq United States
    • 1 July 2019
    ...analysis is consistent with the application of Actavis by circuit courts in recent years. See, e.g., In re Lipitor Antitrust Litig., 868 F.3d 231 (3d Cir. 2017); In re Loestrin 24 Fe Antitrust Litig., 814 F.3d 538 (1st Cir. 2016); King Drug Co. of Florence v. Smithkline Beecham Corp., 791 F......
  • Federal Trade Commission v. AbbVie Inc. (3d Cir. 2020)
    • United States
    • JD Supra United States
    • 13 October 2020
    ...generic), In re Wellbutrin XL Antitrust Litig. Indirect Purchaser Class, 868 F.3d 132 (3d Cir. 2017), and In re Lipitor Antitrust Litig., 868 F.3d 231 (3d Cir. 2017) (settling a related claim for much less than it was objectively worth on one drug and a "no authorized generic" agr......